Eastman Chemical's Q2 EBT Plunges 41% Amid Sales Dip, Rising Costs
Ticker: EMN · Form: 10-Q · Filed: Aug 1, 2025 · CIK: 915389
| Field | Detail |
|---|---|
| Company | Eastman Chemical Co (EMN) |
| Form Type | 10-Q |
| Filed Date | Aug 1, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Chemicals, Earnings Decline, Sales Miss, Restructuring Costs, Environmental Liabilities, Industrial Materials, Q2 2025 Results
Related Tickers: EMN, DOW, LYB, DD
TL;DR
**Sell EMN; Q2 earnings are a disaster with EBT down 41% and no clear path to recovery from rising costs and falling sales.**
AI Summary
Eastman Chemical Co. reported a significant decline in consolidated earnings before income taxes (EBT) for Q2 2025, falling to $169 million from $287 million in Q2 2024, representing a 41.1% decrease. Total operating segments sales also decreased by 3.18% to $2,283 million in Q2 2025 from $2,358 million in Q2 2024. This was primarily driven by a 20.3% drop in Fibers segment sales to $274 million and a 10.1% decrease in Chemical Intermediates sales to $463 million. Advanced Materials sales saw a slight decline of 2.27% to $777 million, while Additives & Functional Products sales increased by 7.1% to $769 million. Adjusted EBIT for total operating segments plummeted by 18.4% to $325 million in Q2 2025 from $398 million in Q2 2024. The company also incurred $13 million in asset impairments, restructuring, and other charges, net, and $40 million in environmental and other costs in Q2 2025, compared to only $16 million in environmental and other costs in Q2 2024, contributing to the EBT decline.
Why It Matters
Eastman Chemical's substantial 41.1% drop in EBT and 3.18% sales decline in Q2 2025 signals potential headwinds for investors, suggesting reduced profitability and market share in a competitive chemical industry. Employees might face increased pressure for cost efficiencies, while customers could see pricing adjustments or shifts in product availability. The broader market may interpret this as a sign of softening demand in key industrial sectors, potentially impacting other chemical manufacturers. Competitors like Dow or LyondellBasell might capitalize on Eastman's struggles, especially in the Fibers and Chemical Intermediates segments.
Risk Assessment
Risk Level: high — The risk level is high due to the significant 41.1% decrease in consolidated EBT from $287 million in Q2 2024 to $169 million in Q2 2025. This decline is exacerbated by a 3.18% drop in total operating segments sales and the incurrence of $13 million in asset impairments and $40 million in environmental costs in Q2 2025, indicating operational challenges and increased expenses.
Analyst Insight
Investors should consider reducing their exposure to EMN given the sharp decline in profitability and sales across multiple segments. Monitor future filings closely for any signs of stabilization in the Fibers and Chemical Intermediates segments, and for management's plans to address rising environmental and restructuring costs.
Financial Highlights
- revenue
- $2,283M
- net Income
- $169M
- revenue Growth
- -3.18%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Advanced Materials | $777M | -2.27% |
| Additives & Functional Products | $769M | +7.1% |
| Chemical Intermediates | $463M | -10.1% |
| Fibers | $274M | -20.3% |
| Total Operating Segments | $2,283M | -3.18% |
Key Numbers
- $169M — Consolidated EBT (Down 41.1% from $287M in Q2 2024)
- $2.28B — Total Operating Segments Sales (Down 3.18% from $2.36B in Q2 2024)
- $274M — Fibers Segment Sales (Down 20.3% from $330M in Q2 2024)
- $463M — Chemical Intermediates Sales (Down 10.1% from $515M in Q2 2024)
- $769M — Additives & Functional Products Sales (Up 7.1% from $718M in Q2 2024)
- $325M — Adjusted EBIT (Total Operating Segments) (Down 18.4% from $398M in Q2 2024)
- $13M — Asset Impairments, Restructuring, and Other Charges (New charge in Q2 2025, not present in Q2 2024)
- $40M — Environmental and Other Costs (Increased from $16M in Q2 2024)
Key Players & Entities
- EASTMAN CHEMICAL CO (company) — filer of the 10-Q
- $169 million (dollar_amount) — Consolidated EBT for Q2 2025
- $287 million (dollar_amount) — Consolidated EBT for Q2 2024
- $2,283 million (dollar_amount) — Total Operating Segments Sales for Q2 2025
- $2,358 million (dollar_amount) — Total Operating Segments Sales for Q2 2024
- $274 million (dollar_amount) — Fibers segment sales for Q2 2025
- $463 million (dollar_amount) — Chemical Intermediates segment sales for Q2 2025
- $13 million (dollar_amount) — Asset impairments, restructuring, and other charges, net for Q2 2025
- $40 million (dollar_amount) — Environmental and other costs for Q2 2025
- $325 million (dollar_amount) — Adjusted EBIT for total operating segments for Q2 2025
FAQ
What were Eastman Chemical's total sales for Q2 2025?
Eastman Chemical's total operating segments sales for Q2 2025 were $2,283 million, a decrease from $2,358 million in Q2 2024.
How did Eastman Chemical's EBT change from Q2 2024 to Q2 2025?
Eastman Chemical's consolidated EBT decreased significantly from $287 million in Q2 2024 to $169 million in Q2 2025, representing a 41.1% decline.
Which Eastman Chemical segment experienced the largest sales decline in Q2 2025?
The Fibers segment experienced the largest sales decline, dropping 20.3% from $330 million in Q2 2024 to $274 million in Q2 2025.
What non-core items impacted Eastman Chemical's EBIT in Q2 2025?
In Q2 2025, non-core items impacting EBIT included $13 million in asset impairments, restructuring, and other charges, net, and $40 million in environmental and other costs.
Did Eastman Chemical's Additives & Functional Products segment grow in Q2 2025?
Yes, the Additives & Functional Products segment sales increased by 7.1% to $769 million in Q2 2025 from $718 million in Q2 2024.
What was the Adjusted EBIT for Eastman Chemical's total operating segments in Q2 2025?
The Adjusted EBIT for Eastman Chemical's total operating segments in Q2 2025 was $325 million, down from $398 million in Q2 2024.
What are the key risks highlighted by Eastman Chemical's Q2 2025 filing?
Key risks include declining sales in major segments like Fibers and Chemical Intermediates, significant increases in environmental costs from $16 million to $40 million, and new asset impairment and restructuring charges of $13 million.
How does Eastman Chemical's Q2 2025 performance compare to the first six months of 2025?
The filing provides Q2 2025 and Q2 2024 data, and first six months 2025 data. For the first six months of 2025, total operating segments sales were $4,568 million, with Advanced Materials at $1,496 million and Additives & Functional Products at $1,502 million.
What is the impact of increased environmental costs on Eastman Chemical's profitability?
Increased environmental and other costs, rising from $16 million in Q2 2024 to $40 million in Q2 2025, directly reduced Eastman Chemical's consolidated EBT by an additional $24 million, contributing to the overall profit decline.
Should investors be concerned about Eastman Chemical's Q2 2025 results?
Yes, investors should be concerned. The 41.1% drop in EBT and 3.18% decline in total sales, coupled with rising non-core costs like asset impairments and environmental expenses, indicate significant operational and financial challenges for Eastman Chemical.
Industry Context
The chemical industry, particularly segments like plastics and synthetic resins, faces cyclical demand influenced by global economic conditions. Eastman Chemical operates in a competitive landscape where raw material costs, supply chain disruptions, and evolving regulatory environments are key factors affecting profitability.
Regulatory Implications
The company's operations are subject to environmental regulations, which can lead to significant costs for compliance and remediation, as evidenced by the increase in 'Environmental and other costs'. Changes in trade policies or chemical safety regulations could also impact market access and operational expenses.
What Investors Should Do
- Monitor the performance of the Fibers and Chemical Intermediates segments, which experienced significant sales declines, to assess the sustainability of these trends.
- Analyze the drivers behind the increase in 'Environmental and other costs' and 'Asset impairments, restructuring, and other charges' to understand their impact on future profitability.
- Evaluate the company's ability to offset declining segment revenues with growth in segments like Additives & Functional Products.
- Assess the impact of macroeconomic factors and competitive pressures on Eastman Chemical's overall revenue and margin performance in the upcoming quarters.
Glossary
- EBT
- Earnings Before Income Taxes. This represents a company's profit before the deduction of income taxes. (A key indicator of profitability, directly impacted by operational performance and non-core charges in the Q2 2025 filing.)
- Adjusted EBIT
- Earnings Before Interest and Taxes, adjusted for certain items. It provides a measure of operating performance excluding financing and tax effects, and sometimes specific non-recurring items. (Used to assess the core operating profitability of the company's segments, showing a significant decline in Q2 2025.)
- Asset impairments, restructuring, and other charges, net
- Costs incurred when the carrying value of an asset exceeds its recoverable amount, or expenses related to reorganizing business operations. (These charges negatively impacted EBT in Q2 2025, contributing to the decline in profitability.)
- Environmental and other costs
- Expenses related to environmental remediation, compliance, or other miscellaneous operational costs. (These costs increased significantly in Q2 2025 compared to Q2 2024, further pressuring earnings.)
Year-Over-Year Comparison
Compared to Q2 2024, Eastman Chemical Co. reported a substantial 41.1% decrease in consolidated EBT, falling to $169 million from $287 million. Total operating segment sales also declined by 3.18% to $2,283 million. This downturn was exacerbated by a significant increase in non-core charges, including $13 million in asset impairments and restructuring, and a rise in environmental costs to $40 million from $16 million in the prior year's quarter.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 1, 2025 regarding EASTMAN CHEMICAL CO (EMN).